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Abstract The genes of the human low Mr phosphotyrosine
protein phosphatase (PTPase) isoforms 1 (IF1) and 2 (IF2) were
isolated by screening a human placenta cDNA library, cloned in
pGEX and expressed in E. coli as fusion proteins with
glutathione S-transferase. The recombinant proteins were
purified by a rapid one-step procedure allowing each enzyme to
purify with high final yield and specific activity. This result is
important for IF1, whose purification from natural sources is
difficult, due to precipitation propensity, thus hindering structur-
al studies. The enzymes obtained showed kinetic parameters very
similar to those previously determined for the enzymes purified
by classical procedures from both human erythrocytes and rat
liver. These recombinant enzymes can therefore be used in place
of those purified from natural sources for every purpose. IF1 and
IF2 crystals were also grown. IF1 crystals were X-ray-grade,
diffracted to better than 2.4 Aî and were suitable for high
resolution X-ray structure determination.
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1. Introduction
Protein tyrosine phosphorylation/dephosphorylation plays
an essential role in regulating cellular events such as prolifer-
ation, di¡erentiation and oncogenesis in mammals [1^3].
These reactions are catalyzed by two classes of unrelated en-
zymes, protein tyrosine kinases and phosphotyrosine protein
phosphatases (PTPases), respectively. In cells, the overall level
of protein phosphorylation on tyrosine is therefore the result
of a balance of the activity of these two classes of highly
regulated enzymes [4].
At present, over ¢fty di¡erent PTPases are known; these
are grouped into several families on the basis of catalytic and
structural features (reviewed in [5]). The enzymes belonging to
di¡erent families do not show any sequence similarity, but all
share a common sequence CXXXXXRS/T (active site signa-
ture motif) containing some of the catalytic residues. In addi-
tion, catalysis of all PTPases proceeds through a cysteinyl-
phosphate intermediate [6]. A group of PTPases comprises a
number of highly homologous cytosolic enzymes formerly
known as low Mr soluble acid phosphatases (E.C. 3.1.3.2)
with molecular masses averaging 18 kDa. In mammals, these
enzymes, presently known as low Mr PTPases (E.C. 3.1.3.48)
(reviewed in [7]), are present as three couples of isoenzymes
(A, B and C), each couple arising from alternative splicing of
a speci¢c allele [8,9]. The isoenzymes of each couple di¡er
from each other only in the 40^73 region and are indicated
as fast (f) or slow (s) form, respectively, on the basis of the
electrophoretic mobility or, alternatively, as isoform 1 (IF1)
and isoform 2 (IF2). Both isoforms hydrolyze phosphotyro-
sine, phosphotyrosine-containing peptides and proteins phos-
phorylated on tyrosine residues such as the activated EGF
and PDGF receptors [10^13]; the enzyme is also able to in-
teract with the stimulated insulin receptor [14] and its activity
appears regulated in vitro and in vivo through phosphoryla-
tion by pp60src and by other kinases of the src family [15,16].
The X-ray crystal structure of the bovine liver IF2 has been
determined at 2.1 Aî resolution [17]. The enzyme is a closely
packed structure formed by a central parallel, open twisted,
four stranded L sheet surrounded on both sides by connecting
helices. In the structure, the active site signature residues form
a smooth loop (P-cradle) connecting the ¢rst K helix to the
¢rst L strand. The overall IF2 structure di¡ers from that of
other PTPases such as PTP1B, Yersinia PTPase and the dual
speci¢city VHR [18^20], although all these enzymes possess
the same P-cradle and similar active site conformations. Clas-
sical PTPases possess the active centre at the bottom of a
crevice whose depth explains the inability of these enzymes
to hydrolyze phosphoserine and phosphothreonine. In most
PTPases, the crevice is lined by basic residues while in the case
of the low Mr PTPases these are mainly hydrophobic and
partly di¡er in IF1 and IF2. This feature can explain some
of the di¡ering catalytic properties of IF1 and IF2; moreover,
it suggests that, in general, the residues lining the active site
pocket can be considered one of the elements representing the
molecular basis of the di¡erential kinetic properties and sub-
strate speci¢city of the varying PTPases [21].
Presently, a relevant number of information is available on
IF2 structural, kinetic and biological features, whereas only
the amino acid sequence and some kinetic data are known
about IF1. The structural studies on IF1 have been hindered
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by the di⁄culty to obtain the enzyme, in a pure, active and
native-like form and with a good yield, from its main natural
sources (erythrocytes and rat liver) where it is present in low
amounts. The description of the IF1 structural features could
provide further information about the molecular basis of the
di¡ering kinetic behavior and substrate preference of either
isoform. For these reasons, we isolated the cDNAs encoding
human IF1 and IF2, respectively, and cloned them in the
pGEX-2T expression vector in E. coli cells. Both isoforms
were puri¢ed by a procedure allowing us to rapidly obtain
high yields of each enzyme in a pure form. In addition, IF1
crystals suitable for X-ray analysis were obtained and their
preliminary characterization is reported.
2. Materials and methods
E. coli Klenow fragment, DNA polymerase I, T4 DNA ligase, Taq
DNA polymerase, polynucleotide kinase, random primer labelling kit
and restriction enzymes were from Promega. Isopropylthiogalactoside
(IPTG), pGEX-2T and oligonucleotide primers were from Pharmacia.
[Q-32P]-ATP (6000 Ci/mmol) and [K-32P]-dATP (3000 Ci/mmol) were
from New England Nuclear. The speci¢c horseradish peroxidase-
linked polyclonal anti-rat liver IF1 and IF2 antibodies used in the
Western blot analysis were obtained as previously described [22].
The sparse matrix crystallization kits were Crystal Screen1 and Crys-
tal Screen II1 from Hampton Research. Glutathione, cGMP, bovine
thrombin and glutathione-agarose a⁄nity gel were from Sigma. All
other reagents were analytical grade or the best commercially avail-
able.
2.1. Oligonucleotide synthesis and enzyme cloning
The sequences of the two synthesized oligonucleotide primers (di-
rect and reverse) were complementary to the conserved regions of the
DNAs encoding either IF1 of the A phenotype or IF2 of the B phe-
notype. The direct primer (‘Bat’) sequence (5P-CCGCGTGGA-
TCCGCGGAACAGGCTACC-3P) included the restriction site for
BamHI. The 3P-end oligonucleotide sequence was complementary to
the sequences at the 5P coding-ends of the cloned cDNAs. The ATG
triplet coding for Met was deleted to get each enzyme with the ap-
propriate N-terminus. The reverse primer (‘Nat9’) (5P-ACCGACCT-
GAGAAATGCAGGA-3P) previously used to sequence the same
cDNA, was complementary to the cDNA 3P-untranslated sequence
and did not contain any restriction site.
The template cDNA was obtained by screening a placenta cDNA
library. The polymerase chain reaction (PCR) experiment was per-
formed at 52‡C under the conditions speci¢ed by the manufacturer,
using 100 pmol of Bat and Nat9 primers, respectively. The fragment
yielding the single 530-bp band, containing the complete IF1 and IF2
coding sequences (480 bp), was extracted from 1.5% agarose using
Sephaglass1 BandPrep kit (Pharmacia) and treated with Klenow to
generate blunt ends at both termini. The fragment was subcloned in
the pGEX-2T vector after overnight digestion with BamHI. The ex-
pression vector was prepared by digestion with EcoRI and treatment
with Klenow to obtain the same blunt ends as the 530-bp fragment;
the vector was also digested with BamHI to produce the same site of
the PCR-coding fragment and puri¢ed on 1.2% agarose gel. The re-
combinant expression vectors (pGEX-IF1 and pGEX-IF2) were gen-
erated by ligating the digested vector and the PCR-coding fragment
(BamHI, blunt). The fragment was inserted downstream in an open
reading frame with the GST sequence. The adequacy of the obtained
cDNAs was checked by sequencing according to Sanger [23] (1977).
Each construct was able to express the corresponding fusion protein
and was used to transform TB1 E. coli.
2.2. Screening of expressing clones
The transformed E. coli cells were selected by ampicillin on agar
plate. One pool of colonies was screened by restriction mapping using
the BamHI-PstI restriction sites present in both the plasmid and the
cloned cDNAs. Two bands of 1.0 and 0.450 kbp appeared, whereas
only the 1.0-kbp band appeared when the wild-type plasmid was
digested, thus demonstrating the presence and the correct orientation
of the insert. The positive clones were checked for fusion protein
expression. Clones were inoculated in 2 ml of LB medium supple-
mented with 100 Wg/ml ampicillin. When cell suspension reached an
optical density of 1.0, expression was induced by adding 0.2 mM
IPTG (¢nal concentration). After 4 h, the suspension was centrifuged
and the pellet resuspended in 100 Wl of 20 mM phosphate-bu¡ered
saline (PBS), pH 7.4, containing 150 mM NaCl, 10 mM 2-mercapto-
ethanol and 1.0 mM ethylenediamine tetraacetic acid (EDTA). The
suspension was sonicated and centrifuged. The clear supernatant was
checked for PTPase activity, run on 12% SDS-PAGE according to
Laemmli [24] (1970) and subjected to Western blot analysis by using
horseradish-conjugated anti-rat liver IF1 or IF2 antibodies, according
to Modesti et al. [25].
Larger amounts of recombinant fusion protein were expressed
under the conditions reported above by scaling up the procedure to
1 l or more growth medium. IPTG was added when the optical den-
sity of the suspension reached 1^2 units. After centrifugation, the
bacterial pellet was stored at 320‡C.
2.3. Protein determination and PTPase activity measurement
Protein concentration of the crude lysates was determined by Coo-
massie brilliant blue assay; in the case of the puri¢ed enzymes, protein
concentration was determined by measuring UV absorption at 280 nm
using an A1%1cm = 1.00 or by amino acid analysis. Enzyme activity was
measured using PNPP or L-phosphotyrosine as substrates as previ-
ously reported [21].
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Fig. 1. Silver-stained 15% SDS-PAGE of puri¢ed IF1 (lane 2) and
IF2 (lane 4). In lane 3 IF1 was run, extracted from the crystals
after washing with the reservoir solution. Lane 1, standard proteins.
From the top: bovine serum albumin (66 kDa), albumin (egg)
(45 kDa), trypsinogen (bovine pancreas, PMSF) (24 kDa), L-lacto-
globulin (subunit) (18.4 kDa).
Table 1
IF1 and IF2 puri¢cation parametersa
Step Volume (ml) Total protein (mg) Total activity (IU) Puri¢cation (fold) Yield (%)
Cell lysate (IF1) 150 200.0 2500 1.0 100.0
Cell lysate (IF2) 150 200.0 7000 1.0 100.0
A⁄nity (IF1) 20 25.0 1492 4.8 59.6
A⁄nity (IF2) 20 35.9 4378 3.5 62.5
aFrom a 2-l culture.
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2.4. Amino acid analysis and mass spectrometry measurements
Amino acid analyses were performed using a Carlo Erba mod.
3A29 apparatus equipped with a computing integrator according to
Manao et al. [26]. Values for serine and threonine were corrected for
degradation during sample hydrolysis. The puri¢ed IF1 and IF2 ion
spray mass spectra were obtained in positive ion mode and recorded
on a Hewlett Packard model 1100 MSD mass spectrometer. Samples
used for the determinations were dissolved in 50% acetonitrile/water
containing 10 mM formic acid.
2.5. Enzyme crystallization and crystal analysis
Optimal crystallization conditions for both IF1 and IF2 were ini-
tially searched using the sparse matrix approach by the hanging drop
vapor di¡usion method in cell culture plates at room temperature and
a protein concentration of about 5.0 mg/ml. The conditions yielding
best crystals were then reproduced and optimized using a ¢ner grid
search. IF1 and IF2 crystals were grown in 3^4 days in drops of about
2 Wl of protein solution to which was added 2 Wl of reservoir solution
(IF1: 40% saturation ammonium sulfate, 0.1 M sodium acetate, pH
5.6 and 10 mM dithiothreitol ; IF2: 32^36% saturation ammonium
sulfate, 0.1 M sodium acetate, pH 5.1 and 10 mM dithiothreitol).
IF1 X-ray di¡raction data were collected on a MAR-research imaging
plate system mounted on a Siemens rotating anode or at the ESRF
(Grenoble) at beam line BM2.
3. Results and discussion
IF1 (allele A) and IF2 (allele B) were expressed in E. coli as
fusion proteins with glutathione S-transferase (see Section 2)
and puri¢ed in milligram quantities using a one-step proce-
dure performed by coupling the glutathione-agarose a⁄nity
chromatography to in-column overnight thrombin cleavage
of the resin-bound IF1-GST or IF2-GST fusion protein, re-
spectively. The frozen bacterial suspension in 20 mM PBS, pH
7.4, containing 1.0 mM EDTA, 10 mM 2-mercaptoethanol
and 150 mM NaCl, was quickly brought to 37‡C, then 1%
Triton X-100 and 0.1 mM phenylmethylsulfonylchloride
(PMSF) (¢nal concentrations) were added; the suspension
was treated with lysozyme (¢nal concentration 1.0 mg/ml)
for 30 min at room temperature and then sonicated 6 times
for 90 s (overall). All subsequent operations were carried out
at 5‡C. The mixture was centrifuged at 12 000Ug for 20 min;
the clear supernatant was diluted to a ¢nal protein concen-
tration of 3^5 mg/ml with 20 mM PBS, pH 7.4, containing 1.0
mM EDTA, 0.1 mM PMSF, 10 mM 2-mercaptoethanol and
150 mM NaCl and assayed for PTPase activity. The super-
natant was run at a £ow rate of 50 ml/h through a 2.5-cm
column ¢lled with 20 ml of agarose-GSH resin (Sigma) equi-
librated with 20 mM PBS, pH 7.4, containing 1.0 mM EDTA,
10 mM 2-mercaptoethanol and 250 mM NaCl. The column
was washed with 15 volumes of the same bu¡er and equili-
brated in 50 mM Tris-HCl bu¡er, pH 8.0, containing 150 mM
NaCl (cleavage bu¡er). The fusion protein was cleaved by
incubating overnight the resin bed in 10 ml of cleavage bu¡er
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Table 2
Main kinetic parameters of puri¢ed human IF1 and IF2a
Parameter IF1 IF2
Apparent Km (mM)b 0.05 (0.06) 0.24 (0.42)
Apparent Km (mM)c 0.34 (n.r.) 5.58 (n.r.)
kcat (s31)b 23.5 (9.9) 25.5 (14.7)
kcat (s31)c 20.3 (n.r.) 8.6 (n.r.)
kcat/Km (s31 M31 103)b 470.0 (162.3) 106.4 (35.0)
kcat/Km (s31 M31 103)c 59.8 (n.r.) 1.5 (n.r.)
Maximum cGMP activation (%)b 114.8 (n.r.) 470.0 (n.r.)
aIn parentheses, the values calculated for enzymes puri¢ed from human erytrocytes [8]; n.r., not reported.
bUsing PNPP as substrate.
cUsing phosphotyrosine as substrate.
Fig. 2. IF1 and IF2 (inset) crystals grown as described in Section 2. Crystal and unit cell parameters are summarized in Table 3.
R. Marzocchini et al./FEBS Letters 426 (1998) 52^5654
containing 4.0 mM CaCl2 and thrombin at a 1:2000 ratio
with respect to the estimated amount of fusion protein bound
to the resin. At the end of the incubation, 0.1 volumes of 250
mM acetate bu¡er, pH 5.5, containing 2.0 M ammonium
sulfate, 10 mM EDTA and 100 mM 2-mercaptoethanol (stor-
age bu¡er) were added immediately, and the solution was
further acidi¢ed to pH 6.0 by adding 0.1 volumes of 0.3 M
acetic acid and assayed for protein content and PTPase activ-
ity. IF1 and IF2 speci¢c activities, about 60 IU/mg and 120
IU/mg, respectively, were slightly higher than those reported
for the same enzymes puri¢ed from natural sources. Finally,
the enzyme was concentrated by ultra¢ltration to about 10.0
mg/ml and its purity checked by SDS-PAGE, amino acid
analysis and electrospray mass spectrometry. The SDS-
PAGE (Fig. 1) of each puri¢ed enzyme showed an unique
band whose molecular mass corresponded to those calculated
for IF1 and IF2, respectively.
The amino acid analyses of the puri¢ed IF1 and IF2 were
consistent with the known protein sequences, taking into ac-
count that both isoenzymes possess a Ser-Gly extension at the
N-terminus due to the presence, in the fusion protein, of the
thrombin cleavage site (PR-GS) between GST and PTPase.
The molecular masses of the puri¢ed IF1 and IF2, as deter-
mined by electrospray mass spectrometry, were 18 082 and
17 992.8, respectively, in agreement with the values calculated
from the amino acid sequences (IF1: 18 083.4 and IF2:
17 990.3), considering both the N-terminus extension and the
lack of N-acetylation due to the expression of each fusion
protein in a prokaryotic system.
The in-column thrombin cleavage of the GST-fusion pro-
teins allowed more rapid puri¢cation of both isoforms and a
higher protein cleavage e⁄ciency. This puri¢cation procedure
considerably reduced IF1 denaturation following thrombin
cleavage, which is usually performed at more alkaline pH;
in addition, the protein is maintained for most of the time
at a concentration s 3 mg/ml, thus preserving it from dena-
turation by dilution. Table 1 reports the IF1 and IF2 puri¢-
cation parameters, showing the good ¢nal yield of puri¢ed
enzyme. In this way it is possible to obtain large amounts
of both IF2 and, particularly, IF1, which is present in natural
sources such as human erythrocytes and rat liver in quite low
amounts and shows propensity to denaturate and precipitate
when it is puri¢ed by conventional procedures.
Table 2 reports the main kinetic parameters of the puri¢ed
recombinant IF1 and IF2. The apparent Km values are very
similar to those previously reported for the same enzymes
puri¢ed from human erythrocytes [8], whereas the kcat (and
hence the kcat/Km) values are quite di¡erent. This apparent
discrepancy can be explained taking into account that the
values previously reported [8] were calculated at pH 6.0 in-
stead of 5.5, a value closer to the pH optimum; in addition, as
it has been pointed out, our puri¢cation procedure yields both
enzymes, particularly IF1, mostly in the native, undenatured
state, contrary to the classical puri¢cation procedure, thus
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Table 3
Cell parameters of IF1 crystals
Space group (Aî ) Cell (Aî ) Vm (Aî 3/Da) Di¡raction limit
P6522 a,b = 60.4, c = 167.8 2.46 2.4
Fig. 3. X-ray di¡ractogram of IF1 crystals.
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explaining the substantially higher speci¢c activity value. Thus
our results indicate that the lower (about 2/3) speci¢c activity
of IF1 with respect to IF2 reported by a number of authors is
substantially attributable to the higher propensity to denatu-
ration of the latter. A higher susceptibility to thermal denatu-
ration of IF1 with respect to IF2 was previously reported [8].
The e¡ect of cGMP on the puri¢ed recombinant enzymes is
very similar to that found for the corresponding enzymes
puri¢ed from rat liver [27,28]. In fact, only the IF2 catalytic
behavior is a¡ected by the presence of cGMP and the extent
of activation is the same as that previously reported. These
data indicate that the puri¢ed recombinant IF1 and IF2 main-
tain the same catalytic behavior as their natural counterparts
and can therefore be used in substitution of these for every
kind of kinetic as well as structural and biological study.
Recombinant IF1 and IF2 crystals were grown at room
temperature as described in Section 2. The SDS-PAGE of
IF1 redissolved from the crystals is shown in Fig. 1. Isomor-
phous IF1 crystals were reproducibly grown in 3^4 days in
40% saturation ammonium sulfate, pH 5.6, containing 0.1 M
sodium acetate and 10 mM dithiothreitol. IF1 crystals belong-
ing to space group P6522 appeared as hexagonal prisms of
typical dimensions 1.2U0.2U0.2 mm (Fig. 2), with unit cell
dimensions at room temperature of a, b = 60.4 Aî , c = 167.8 Aî
and a Vm value of 2.46 Aî 3/Da (Table 3), which is in the
middle of the expected range and very similar to that reported
for IF2 crystals previously obtained from the bovine liver
enzyme [29]. These crystals di¡racted to better than 2.4 Aî
on a rotating anode X-ray source and were well suited for
high resolution crystallographic studies. Fig. 3 shows a dif-
fractogram of an IF1 crystal obtained as indicated in Section
2.
IF2 crystals could also be grown under the conditions re-
ported in Section 2. These small plate-like crystals (Fig. 2,
inset) di¡racted to 2.5 Aî at beamline BM2 at the ESRF.
However, the IF2 crystals have not yet been obtained as
non-twinned single crystals, which did not allow further char-
acterization. At any rate, our purpose was the achievement of
good IF1 crystals useful for X-ray structural studies and, par-
ticularly, for enzyme structure determination.
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